Association between daily coffee intake and diabetic kidney disease: evidence from the 2007 to 2016 NHANES
- PMID: 40172611
- DOI: 10.1007/s11255-025-04480-8
Association between daily coffee intake and diabetic kidney disease: evidence from the 2007 to 2016 NHANES
Abstract
Purpose: Regular coffee intake is recognized as a protective factor against various chronic diseases, particularly diabetes. However, the correlation between coffee intake-both the act of drinking coffee and the amount consumed-and diabetic kidney disease (DKD) remains uncertain. The goal of this study is to measure the correlation between coffee intake and DKD.
Methods: This cross-sectional study was based on data from the 2007 to 2016 National Health and Nutrition Examination Survey (NHANES). DKD was characterized by the coexistence of diabetes combined with impaired glomerular filtration rate (eGFR < 60 mL/min/1.73 m2) or ACR ≥ 30 mg/g. Weighted logistic regression and restricted cubic spline (RCS) analyses were adopted to evaluate the correlation between coffee intake and DKD. The subgroup analyses were implemented to assess the reliability of the results.
Results: The study included 13,177 participants, representing a weighted population of 125,388,198 individuals. Among them, 8198 (64%) participants consumed coffee and 1430 (7.6%) were classified as having DKD. After controlling for covariates, multivariable logistic regression showed a negative correlation between moderate coffee intake and DKD (OR = 0.68; 95% CI: 0.55-0.83; P < 0.001). The RCS analysis suggested a U-shaped, non-linear correlation between coffee intake and DKD (P overall = 0.013; P nonlinear = 0.047). The subgroup analyses further supported the stability and reliability of these findings.
Conclusion: The results indicate a U-shaped correlation between coffee intake and diabetic kidney disease.
Keywords: Coffee intake; Diabetic kidney disease; NHANES; eGFR.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval and consent to participate: Not applicable. Consent for publication: Not applicable.
Similar articles
-
The relationship between flavonols intake and stroke in the elderly: a cross-sectional study from NHANES (2007-2010 and 2017-2018).J Stroke Cerebrovasc Dis. 2025 Aug;34(8):108373. doi: 10.1016/j.jstrokecerebrovasdis.2025.108373. Epub 2025 Jun 7. J Stroke Cerebrovasc Dis. 2025. PMID: 40490174
-
Decreased Serum Adipose Triglyceride Lipase Level Is Associated With Renal Function Impairment in Patients With Type 2 Diabetes.J Diabetes Res. 2025 Jul 24;2025:9987648. doi: 10.1155/jdr/9987648. eCollection 2025. J Diabetes Res. 2025. PMID: 40747293 Free PMC article.
-
Association between uric acid to high-density lipoprotein cholesterol ratio and diabetic kidney disease in US adults.Sci Rep. 2025 Jul 8;15(1):24353. doi: 10.1038/s41598-025-09999-5. Sci Rep. 2025. PMID: 40629003 Free PMC article.
-
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.JBI Database System Rev Implement Rep. 2016 Jul;14(7):169-207. doi: 10.11124/JBISRIR-2016-003011. JBI Database System Rev Implement Rep. 2016. PMID: 27532796
-
Protein restriction for diabetic kidney disease.Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2. Cochrane Database Syst Rev. 2023. PMID: 36594428 Free PMC article.
References
-
- Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12(12):2032–2045. https://doi.org/10.2215/cjn.11491116 - DOI - PubMed - PMC
-
- Fenta ET, Eshetu HB, Kebede N, Bogale EK, Zewdie A, Kassie TD et al (2023) Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis. Diabetol Metab Syndr 15(1):245. https://doi.org/10.1186/s13098-023-01202-x - DOI - PubMed - PMC
-
- Jiang W, Wang J, Shen X, Lu W, Wang Y, Li W et al (2020) Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts. Diabetes Care 43(4):925–933. https://doi.org/10.2337/dc19-1897 - DOI - PubMed
-
- Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J et al (2014) Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 64(4):510–533. https://doi.org/10.1053/j.ajkd.2014.08.001 - DOI - PubMed
-
- Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF (2024) Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev 4(4):Cd006257. https://doi.org/10.1002/14651858.CD006257.pub2 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous